Up-regulation of activation-induced cytidine deaminase causes genetic aberrations at the CDKN2b-CDKN2a in gastric cancer.
暂无分享,去创建一个
K. Kinoshita | Y. Matsumoto | H. Marusawa | T. Chiba | Y. Sakai | Y. Niwa
[1] H. Marusawa,et al. A novel mechanism for inflammation-associated carcinogenesis; an important role of activation-induced cytidine deaminase (AID) in mutation induction , 2009, Journal of Molecular Medicine.
[2] M. Lieber,et al. The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. , 2009, Cancer cell.
[3] G. Bornkamm,et al. Epstein‐Barr virus and the pathogenesis of Burkitt's lymphoma: More questions than answers , 2009, International journal of cancer.
[4] M. Potter,et al. Restricting activation‐induced cytidine deaminase tumorigenic activity in B lymphocytes , 2009, Immunology.
[5] T. Honjo,et al. A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations , 2009, Oncogene.
[6] T. Honjo,et al. Organ‐specific profiles of genetic changes in cancers caused by activation‐induced cytidine deaminase expression , 2008, International journal of cancer.
[7] M. Nussenzweig,et al. AID Is Required for the Chromosomal Breaks in c-myc that Lead to c-myc/IgH Translocations , 2008, Cell.
[8] R. Siebert,et al. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge , 2008, Leukemia.
[9] T. Honjo,et al. Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers. , 2008, Gastroenterology.
[10] F. Alt,et al. AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development , 2008, The Journal of experimental medicine.
[11] K. Kinoshita,et al. Activation‐induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma , 2008, Hepatology.
[12] T. Ried,et al. AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements , 2007, The Journal of experimental medicine.
[13] M. Nussenzweig,et al. A role for AID in chromosome translocations between c-myc and the IgH variable region , 2007, The Journal of experimental medicine.
[14] T. Honjo,et al. Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling , 2007, Oncogene.
[15] T. Honjo,et al. Detection of activation-induced cytidine deaminase in gastric epithelial cells infected with cag pathogenicity island-positive Helicobacter pylori , 2007 .
[16] Takeshi Azuma,et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium , 2007, Nature Medicine.
[17] T. Ushijima. Epigenetic field for cancerization. , 2007, Journal of biochemistry and molecular biology.
[18] K. Kinoshita,et al. Expression of activation‐induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis , 2007, International journal of cancer.
[19] W. Hofmann,et al. Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1–transformed acute lymphoblastic leukemia cells , 2007, The Journal of experimental medicine.
[20] N. Sharpless,et al. The Regulation of INK4/ARF in Cancer and Aging , 2006, Cell.
[21] J. Yokota,et al. Molecular processes of chromosome 9p21 deletions causing inactivation of the p16 tumor suppressor gene in human cancer: deduction from structural analysis of breakpoints for deletions. , 2006, DNA repair.
[22] G. Peters,et al. Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all , 2006, Nature Reviews Molecular Cell Biology.
[23] T. Ushijima,et al. DNA methylation as a marker for the past and future , 2006, Journal of Gastroenterology.
[24] K. Kinoshita,et al. The Dark Side of Activation-Induced Cytidine Deaminase: Relationship with Leukemia and Beyond , 2006, International journal of hematology.
[25] Michel C. Nussenzweig,et al. Role of genomic instability and p53 in AID-induced c-myc–Igh translocations , 2006, Nature.
[26] G. Tamura. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. , 2006, World journal of gastroenterology.
[27] A. Levine,et al. Eradication of Helicobacter pylori and Resolution of Gastritis in the Gastric Mucosa of IL‐10‐Deficient Mice , 2005, Helicobacter.
[28] M. Nussenzweig,et al. AID Is Required for c-myc/IgH Chromosome Translocations In Vivo , 2004, Cell.
[29] U. Storb,et al. The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. , 2003, Immunity.
[30] Hui Zhang,et al. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA , 2003, Nature.
[31] N. Kakazu,et al. Constitutive Expression of AID Leads to Tumorigenesis , 2003, The Journal of experimental medicine.
[32] J. Wedekind,et al. Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business. , 2003, Trends in genetics : TIG.
[33] T. Honjo,et al. De novo protein synthesis is required for the activation-induced cytidine deaminase function in class-switch recombination , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[34] S. Lowe,et al. Tumor suppression by Ink4a-Arf: progress and puzzles. , 2003, Current opinion in genetics & development.
[35] Jun Yu,et al. Promoter hypermethylation of tumor‐related genes in gastric intestinal metaplasia of patients with and without gastric cancer , 2002, International journal of cancer.
[36] William C Hahn,et al. Rules for making human tumor cells. , 2002, The New England journal of medicine.
[37] K. Okazaki,et al. Analysis of Cytokines in the Early Development of Gastric Secondary Lymphoid Follicles in Helicobacter pylori-Infected BALB/c Mice with Neonatal Thymectomy , 2001, Infection and Immunity.
[38] Jun Yu,et al. Concurrent hypermethylation of multiple tumor‐related genes in gastric carcinoma and adjacent normal tissues , 2001, Cancer.
[39] T. Honjo,et al. Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.
[40] K. Kinzler,et al. Genetic instabilities in human cancers , 1998, Nature.
[41] T. Dryja,et al. Short, direct repeats at the breakpoints of deletions of the retinoblastoma gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[42] H. Marusawa. Aberrant AID expression and human cancer development. , 2008, The international journal of biochemistry & cell biology.
[43] R. Kefford,et al. The ARF tumour suppressor. , 2006, The international journal of biochemistry & cell biology.
[44] T. Honjo,et al. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. , 2002, Annual review of immunology.
[45] S. Korsmeyer,et al. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. , 1992, Annual review of immunology.